Search - tctmd.com

Displaying 1 - 4 of 4

Sort: Relevancy | Date

The HOST-Reduce-Polytech-ACS trial: Durable Polymer versus Biodegradable Polymer Drug-Eluting Stents after percutaneous coronary intervention in patients with Acute Coronary Syndrome

Presentation TCT 2020

The HOST-Reduce-Polytech-ACS trial: Durable Polymer versus Biodegradable Polymer Drug-Eluting Stents after percutaneous coronary intervention in patients with Acute Coronary Syndrome

Presenter: Hyo-Soo Kim

October 17, 2020

Biodegradable vs Durable Polymer DES Outcomes

Presentation CCVVC 2016

Biodegradable vs Durable Polymer DES Outcomes

Presenter: Ajay J. Kirtane

June 16, 2016

Abluminal biodegradable polymer biolimus-eluting stent versus durable polymer everolimus-eluting stent in patients undergoing primary percutaneous coronary intervention: 3 Year___

Presentation TCT 2014

Abluminal biodegradable polymer biolimus-eluting stent versus durable polymer everolimus-eluting stent in patients undergoing primary percutaneous coronary intervention: 3 Year___

Presenter: Georgios Vlachojannis

September 16, 2014

Effect of Biolimus-Eluting Stents with Biodegradable Polymer vs. BMS on Cardiovascular Events in AMI

Presentation

Effect of Biolimus-Eluting Stents with Biodegradable Polymer vs. BMS on Cardiovascular Events in AMI

Presenter: L. R?ber

August 21, 2012

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.